Results 111 to 120 of about 6,000,123 (363)

Nicotinamide N‐methyltransferase promotes drug resistance in lung cancer, as revealed by nascent proteomic profiling

open access: yesMolecular Oncology, EarlyView.
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou   +5 more
wiley   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham   +21 more
wiley   +1 more source

Shrinking projection method for proximal split feasibility and fixed point problems

open access: yesResults in Nonlinear Analysis, 2019
In this paper, we consider and study proximal split feasibility and fixed point problem. For solving the problems, we introduce an iterative algorithm with shrinking projection technique. It is proven that the sequence generated by the proposed iterative
Jinzuo Chen
doaj  

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

open access: yesMolecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan   +9 more
wiley   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

Analytic and empirical study of the rate of convergence of some iterative methods

open access: yesJournal of Numerical Analysis and Approximation Theory, 2015
We study analytically and empirically the rate of convergence of two \(k\)-step fixed point iterative methods in the family of methods \[ x_{n+1}=T(x_{i_0+n-k+1},x_{i_1+n-k+1},\dots, x_{{i_{k-1}+n-k+1}}),\,n\geq k-1, \] where \(T\colon X^k\rightarrow ...
Vasile Berinde   +2 more
doaj   +2 more sources

ITERATIVE METHODS FOR APPROXIMATION OF FIXED POINTS AND THEIR APPLICATIONS

open access: yesJournal of the Operations Research Society of Japan, 2000
Summary: We deal with iterative methods for approximation of fixed points and their applications. We first discuss fixed point theorems for a nonexpansive mapping or a family of nonexpansive mappings. In particular, we state a fixed point theorem which answered affirmatively a problem posed during the Conference on Fixed Point Theory and Applications ...
openaire   +2 more sources

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy